glp-1 usage statistics Poll: 1 in 8 Adults Say They've Taken a Drug, Including 4 in 10 of Those with Diabetes and 1 in 4 of Those with Heart Disease GLP-1 Receptor Agonist Market Size
Description
2025;zwaf560
efficacy, safety and clinical implications for type 2 diabetes mellitus
Consume a high-quality diet with adequate protein while using these medications
A recent large-scale clinical trial has confirmed that tirzepatide, a dual GIP and GLP-1RAs, resulted in a weight loss of up to 20.9% in adults with body fat mass of 30 or more after 72-week follow-up [22]
Because like I said [00:54:00] before, being smaller at any cost
